Literature DB >> 32034711

Cytoskeleton and Nucleotide Signaling in Glioma C6 Cells.

Wanda Kłopocka1, Jarosław Korczyński2, Paweł Pomorski2.   

Abstract

This chapter describes signaling pathways, stimulated by the P2Y2 nucleotide receptor (P2Y2R), that regulate cellular processes dependent on actin cytoskeleton dynamics in glioma C6 cells. P2Y2R coupled with G-proteins, in response to ATP or UTP, regulates the level of iphosphatidylinositol-4,5-bisphosphate (PIP2) which modulates a variety of actin binding proteins and is involved in calcium response and activates Rac1 and RhoA proteins. The RhoA/ROCK signaling pathway plays an important role in contractile force generation needed for the assembly of stress fibers, focal adhesions and for tail retraction during cell migration. Blocking of this pathway by a specific Rho-kinase inhibitor induces changes in F-actin organization and cell shape and decreases the level of phosphorylated myosin II and cofilin. In glioma C6 cells these changes are reversed after UTP stimulation of P2Y2R. Signaling pathways responsible for this compensation are calcium signaling which regulates MLC kinase activation via calmodulin, and the Rac1/PAK/LIMK cascade. Stimulation of the Rac1 mediated pathway via Go proteins needs additional interaction between αvβ5 integrins and P2Y2Rs. Calcium free medium, or growing of the cells in suspension, prevents Gαo activation by P2Y2 receptors. Rac1 activation is necessary for cofilin phosphorylation as well as integrin activation needed for focal complexes formation and stabilization of lamellipodium. Inhibition of positive Rac1 regulation prevents glioma C6 cells from recovery of control cell like morphology.

Entities:  

Keywords:  Actin dynamics; Cell migration; Cofilin; Glioma C6 cells; Integrins; Myosin II; P2Y2; PIP2; Rac; Rho; Small G-proteins

Mesh:

Substances:

Year:  2020        PMID: 32034711     DOI: 10.1007/978-3-030-30651-9_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

Review 2.  The Expressions and Mechanisms of Sarcomeric Proteins in Cancers.

Authors:  Xiaojing Yang; Hanru Ren; Xiaomao Guo; Chaosu Hu; Jie Fu
Journal:  Dis Markers       Date:  2020-06-30       Impact factor: 3.434

3.  Acquisition of New Migratory Properties by Highly Differentiated CD4+CD28null T Lymphocytes in Rheumatoid Arthritis Disease.

Authors:  Beatriz Rioseras; Marco Antonio Moro-García; Alejandra García-Torre; Eva Bueno-García; Rocio López-Martínez; Maria Iglesias-Escudero; Roberto Diaz-Peña; Patricia Castro-Santos; Miguel Arias-Guillén; Rebeca Alonso-Arias
Journal:  J Pers Med       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.